ipi/nivo in metastatic nsclc
Published 6 years ago • 239 plays • Length 3:24Download video MP4
Download video MP3
Similar videos
-
3:24
pembro /- ipi in metastatic nsclc: keynote-598
-
5:23
keynote-598: pembro ipi in metastatic nsclc
-
7:16
checkmate 9la study: nivo ipi in nsclc
-
7:22
early updates from the checkmate73l study: nivo ccrt followed by nivo ipi in nsclc
-
1:20
pixatimod and nivolumab in metastatic melanoma, nsclc and mss crc
-
1:18
dr. reck on the safety of pembrolizumab in keynote-024 in metastatic nsclc
-
6:01
metastatic rcc: using frontline ipilimumab/nivolumab
-
10:34
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
6:13
checkmate-227: testing ipilimumab/nivolumab in nsclc
-
6:03
checkmate 9la: nivolumab, ipilimumab and chemotherapy for stage iv nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
10:32
the keynote-189 trial for untreated metastatic nonsquamous nsclc
-
1:22
dr. reck on safety data from the checkmate-9la trial in metastatic/recurrent nsclc
-
1:01
dr. heymach on nivolumab for lung cancer
-
2:44
cancer immunotherapy with nivolumab plus ipilimumab vs. chemotherapy: insights from checkmate 227
-
17:08
three-year update from the checkmate 227 clinical trial for advanced nsclc
-
6:07
interpreting the results of checkmate-227 in nsclc
-
5:51
checkmate-227 and the role of tmb in nsclc
-
1:08
dr. donington on the role of neoadjuvant immunotherapy in stage ii nsclc